ATRA
Time to buy ATRA?Atara Biotherapeutics Inc.
$10.51
$-0.75 (-6.66%)Prices delayed. Get real-time quotes here!
2 Days. Real Options Skills.
Join options trader Ben Sturgill as he reveals his most reliable options strategies - live. Seats are limited.
Save your seatTrader's Perspective
ATRA ran from about $5.15 to $12.43 in May after the company said the Food and Drug Administration outlined a path to resubmit the tabelecleucel filing.
RANGE
CURRENT: $10.51
Support: $9.50 Target: $14
Support: $9.50Current: $10.51 Target: $14
BEARISH SCENARIO
A failure to hold $9.50 could see a retrace toward the $7.00 to $8.00 range. Any weak third quarter regulatory update, more dilution through the at the market share sale program, or renewed delisting pressure would accelerate the downside.
BULLISH SCENARIO
If ATRA holds the $9.50 to $10.00 zone and volume stays active, a push back toward $12.00 to $14.00 is on the table. Resistance at $11.50 is the first hurdle.
CATALYSTS:
Analysis generated: May 30, 2026 at 6:33 AM ET
Analyst Ratings
N/A
Average Price Target: $0
Based on 0 analyst ratings in the last 3 months
Sell
0
Hold
0
Buy
0
Atara Biotherapeutics Inc. Earnings
We don't currently have information about Atara Biotherapeutics Inc.'s earnings.